Icomb

Amlodipine and Ramipril, the active ingredients in Icomb, are calcium channel blocker and ACE inhibitor respectively, presented as an oral tablet for oral use. They treat hypertension in adult patients.

GNH USA supplies Icomb as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Icomb, a combination antihypertensive, is indicated for conditions related to high blood pressure.

- Hypertension: reduces systolic and diastolic blood pressure and lowers cardiovascular risk. - Essential hypertension: provides consistent blood‑pressure control in primary hypertension. - High blood pressure: assists in achieving target blood‑pressure levels in patients with elevated readings.

Common Side Effects: - Headache: mild to moderate headache may occur. - Peripheral edema: swelling of ankles or feet is frequently reported. - Dizziness: transient light‑headedness, especially after first doses. - Flushing: warm sensation and reddening of skin. - Cough: dry cough associated with ACE‑inhibitor component. - Fatigue: general tiredness or lack of energy.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway requiring urgent care. - Severe hypotension: marked drop in blood pressure leading to fainting. - Acute kidney injury: sudden decline in renal function, especially in patients with pre‑existing kidney disease.

Before initiating therapy, clinicians should evaluate patient history and monitor relevant parameters. - Blood pressure monitoring: check regularly to ensure therapeutic response. - Renal function assessment: evaluate serum creatinine and eGFR before and during treatment. - Pregnancy avoidance: do not use in pregnant women due to fetal risk. - Electrolyte balance: monitor potassium levels when combined with potassium‑sparing agents. - Hepatic impairment: use with caution in patients with significant liver disease. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Icomb may interact with several drug classes; careful review is advised.

Major Interactions (Avoid): - Concurrent ACE inhibitors or ARBs: risk of additive renal impairment and hyperkalemia. - Aliskiren in diabetic patients: may cause severe hypotension and renal dysfunction. - Potassium‑sparing diuretics: increase risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise amlodipine levels. - NSAIDs: can blunt antihypertensive effect and affect renal function. - Lithium: monitor lithium levels as ACE‑inhibitors may increase them. - Grapefruit juice: may modestly increase amlodipine exposure.